DK3298006T3 - Antifungal 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorphenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl)benzamid eller et farmaceutisk acceptabelt salt deraf - Google Patents

Antifungal 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorphenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl)benzamid eller et farmaceutisk acceptabelt salt deraf Download PDF

Info

Publication number
DK3298006T3
DK3298006T3 DK16724958.0T DK16724958T DK3298006T3 DK 3298006 T3 DK3298006 T3 DK 3298006T3 DK 16724958 T DK16724958 T DK 16724958T DK 3298006 T3 DK3298006 T3 DK 3298006T3
Authority
DK
Denmark
Prior art keywords
difluorphenyl
hydroxycyclohexyl
piperazin
triazol
benzamide
Prior art date
Application number
DK16724958.0T
Other languages
Danish (da)
English (en)
Inventor
Thomas Christopher Colley
Kazuhiro Ito
Peter Strong
Mihiro Sunose
Matthew Mcconville
Original Assignee
Pulmocide Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pulmocide Ltd filed Critical Pulmocide Ltd
Application granted granted Critical
Publication of DK3298006T3 publication Critical patent/DK3298006T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16724958.0T 2015-05-21 2016-05-20 Antifungal 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorphenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl)benzamid eller et farmaceutisk acceptabelt salt deraf DK3298006T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15168637 2015-05-21
PCT/GB2016/051467 WO2016185225A1 (en) 2015-05-21 2016-05-20 Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof.

Publications (1)

Publication Number Publication Date
DK3298006T3 true DK3298006T3 (da) 2020-03-30

Family

ID=53267232

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16724958.0T DK3298006T3 (da) 2015-05-21 2016-05-20 Antifungal 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorphenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl)benzamid eller et farmaceutisk acceptabelt salt deraf

Country Status (16)

Country Link
US (3) US9969720B2 (cg-RX-API-DMAC7.html)
EP (1) EP3298006B1 (cg-RX-API-DMAC7.html)
JP (1) JP6811727B2 (cg-RX-API-DMAC7.html)
KR (1) KR102653821B1 (cg-RX-API-DMAC7.html)
CN (1) CN107635988B (cg-RX-API-DMAC7.html)
AU (1) AU2016263669B2 (cg-RX-API-DMAC7.html)
CA (1) CA2981945C (cg-RX-API-DMAC7.html)
DK (1) DK3298006T3 (cg-RX-API-DMAC7.html)
EA (1) EA032454B1 (cg-RX-API-DMAC7.html)
ES (1) ES2790723T3 (cg-RX-API-DMAC7.html)
HU (1) HUE048843T2 (cg-RX-API-DMAC7.html)
IL (1) IL254943B (cg-RX-API-DMAC7.html)
MX (1) MX379586B (cg-RX-API-DMAC7.html)
NZ (1) NZ735783A (cg-RX-API-DMAC7.html)
SG (1) SG11201708007VA (cg-RX-API-DMAC7.html)
WO (1) WO2016185225A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107635988B (zh) * 2015-05-21 2021-06-18 普尔莫赛德有限公司 抗真菌的苯甲酰胺类衍生物或其可药用盐
CN109329288A (zh) * 2018-11-09 2019-02-15 青岛农业大学 伏立康唑在制备用于防治植物病原菌的杀菌剂中的应用
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
JPH0717634B2 (ja) * 1987-11-20 1995-03-01 シェリング・コーポレーション トリ‐およびテトラ‐置換‐オキセタンおよびテトラヒドロフランおよびその中間体
US5039676A (en) * 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
JP2834889B2 (ja) * 1993-12-21 1998-12-14 シェーリング コーポレイション テトラヒドロフラン抗真菌剤
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
DE69628117T2 (de) 1995-06-02 2004-04-01 Schering Corp. Antifungale tetrahydrofurane
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
KR100607742B1 (ko) * 2001-04-03 2006-08-01 쉐링 코포레이션 안정한 액상 현탁제, 및 이를 함유하는, 생체 이용율이 증진된 항진균성 조성물
EP1870405A1 (en) * 2006-06-22 2007-12-26 Bioprojet Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands
CN101402613B (zh) * 2008-11-14 2013-07-24 中国人民解放军第二军医大学 取代酚氧烷基胺三唑醇类抗真菌化合物及其制备方法
CN102234267A (zh) * 2010-04-21 2011-11-09 中国科学院上海药物研究所 新型三氮唑类抗真菌化合物、其药物组合物及其制备方法和用途
WO2013036866A1 (en) * 2011-09-07 2013-03-14 The Johns Hopkins University Itraconazole analogs and use thereof
KR102579848B1 (ko) 2014-12-05 2023-09-18 풀모사이드 리미티드 항진균 화합물
CN107635988B (zh) * 2015-05-21 2021-06-18 普尔莫赛德有限公司 抗真菌的苯甲酰胺类衍生物或其可药用盐

Also Published As

Publication number Publication date
KR20180010189A (ko) 2018-01-30
KR102653821B1 (ko) 2024-04-02
CA2981945C (en) 2023-08-29
CA2981945A1 (en) 2016-11-24
EP3298006B1 (en) 2020-01-01
JP6811727B2 (ja) 2021-01-20
CN107635988B (zh) 2021-06-18
HUE048843T2 (hu) 2020-08-28
MX379586B (es) 2025-03-11
US20180251453A1 (en) 2018-09-06
CN107635988A (zh) 2018-01-26
US10280155B2 (en) 2019-05-07
MX2017014814A (es) 2018-02-15
EA032454B1 (ru) 2019-05-31
EA201792558A1 (ru) 2018-05-31
ES2790723T3 (es) 2020-10-29
EP3298006A1 (en) 2018-03-28
US20190202813A1 (en) 2019-07-04
HK1252779A1 (en) 2019-05-31
AU2016263669B2 (en) 2020-04-30
IL254943A0 (en) 2017-12-31
SG11201708007VA (en) 2017-12-28
WO2016185225A1 (en) 2016-11-24
US20170114047A1 (en) 2017-04-27
NZ735783A (en) 2021-12-24
BR112017020807A2 (pt) 2018-07-03
IL254943B (en) 2021-01-31
AU2016263669A1 (en) 2017-10-12
JP2018520104A (ja) 2018-07-26
US10513511B2 (en) 2019-12-24
US9969720B2 (en) 2018-05-15

Similar Documents

Publication Publication Date Title
LT3999180T (lt) (r)-n-(5-(5-etil-1,2,4-oksadiazol-3-il)-2,3-dihidro-1h-inden-1-il)-1-metil-1h-pirazol-4-karboksamido polimorfai
HUE050369T2 (hu) N - ((1,2,3,5,6,7-hexahidro-S-indacen-4-il) -karbamoil)-1-izopropil-1H-pirazol-3-szulfonamid nátrium-sója
EP3886563A4 (en) HIGH CAPACITY BALER
CY2024024I2 (el) Υδροχλωρικα αλατα ν-(κυανομεθυλ)-4-(2-(4- μορφολινοφαινυλαμινο)πυριμιδιν-4-υλ)βενζαμιδιου
IL289515A (en) Mixtures comprising indazole pesticides
NZ719975A (en) Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
IL257390B (en) Salts of 1-((4-methoxymethyl)-4-(((s2,r1)-2-phenyl-cyclopropylamine)methyl)piperidine-1-yl)methyl)-cyclobutane-carboxylic acid as lsd1 inhibitors
DE112017000206T8 (de) Kompensation von Temperaturschwankungen eines Arbeitsspeichers
HUE054042T2 (hu) Pirazolvegyületek és eljárás a vegyületek elõállítására és alkalmazásuk
EP3374638A4 (en) PISTON BALL GUIDE FOR A BALL PUMP
HUE047666T2 (hu) Eljárás 2-[4-(4-Klórfenoxi)-2-(trifluormetil)fenil]-1-(1,2,4-triazol-1-il)-2-propanol elõállítására
DK3303305T3 (da) 2-(phenyloxy eller phenylthio)pyrimidin-derivater som herbicider
EP3685701A4 (en) PRESSURE RELIEF BACKPACK
EP3387659A4 (en) BULK MLCC CAPACITOR MODULE
EP3380774A4 (en) CONTAINER FOR VARIABLE PRINTING
EP3673485A4 (en) MEMORY WITH VIRTUAL PAGE SIZE
DK3395342T3 (da) Tablet omfattende 1-(3-(2-(1-benzothiophen-5-YL)ethoxy)propyl)azetidin-3-ol eller salt deraf
HUE063043T2 (hu) Eljárás N-(5-(4-(4-formil-3-fenil-1H-pirazol-1-il)-pirimidin-2-il-amino)-4-metoxi-2-morfolinofenil)-akrilamid elõállítására
EP3528632C0 (en) REDUCED INHALATION RISK OF QUATERNARY AMMONIUM COMPOUNDS ASSOCIATED WITH A PH-DEPENDENT PHYSIOLOGICAL RESPONSE
IT201600131283A1 (it) Testata raccoglitrice per macchina per la raccolta di cereali
HUE045226T2 (hu) Herbicid hatású N-(1,3,4-oxadiazol-2-il)arilkarboxamid-származékok
EP3402643A4 (en) CONTROLLED PRESSURE CASE
DK3909584T3 (da) Pyrimidinforbindelse eller salt deraf
DK3298006T3 (da) Antifungal 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorphenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl)benzamid eller et farmaceutisk acceptabelt salt deraf
MX384034B (es) Agente terapeutico para cancer de mama.